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Chronic kidney disease
Regional variation in Australia
Chronic kidney disease is a common and serious 
problem in Australia and its management can be 
resource intensive, particularly for the most severe form 
of the disease: end-stage kidney disease. 
Rates of chronic kidney disease vary by geographic 
location. This report shows:
- people from Remote and very remote areas were 2.2 
times more likely to die from chronic kidney disease than 
people from Major cities.
- people from Very remote areas were at least 4 times 
more likely to start kidney replacement therapy (dialysis 
or kidney transplant) than people from non-remote 
areas.
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Summary 
Chronic kidney disease (CKD) is a common and serious problem in Australia and its 
management can be resource intensive. Those with CKD’s most severe form, end-stage 
kidney disease (ESKD), usually require kidney replacement therapy (KRT) to survive, either 
in the form of dialysis or kidney transplantation.  
As with other chronic conditions, the prevalence and incidence of CKD varies by where 
people live. This report provides a detailed picture of how CKD varies in Australia according 
to geographic location. Differences are explored in the incidence, prevalence, treatment, 
hospitalisations, deaths and the effect of Indigenous status on CKD and ESKD. This report 
also examines the relocation of patients when undergoing treatment for ESKD. 
The mortality rate for CKD-related deaths was higher in Remote and very 
remote areas than in other regions 
In 2010, the age-standardised rate of deaths with an underlying cause of CKD was 
considerably higher in more remote areas than in urban areas for both males and females. 
For males the death rate was 19 deaths per 100,000 population in Remote and very remote 
areas, compared to 13 deaths per 100,000 in Major cities. For females the comparable figures 
were 29 and 10 deaths per 100,000 population.  
Remote and Very remote areas have higher rates of new cases of treated-ESKD 
than other areas 
In 2008–10, the rate of new cases of treated-ESKD was highest in Remote and Very remote 
areas (19 and 44 cases per 100,000 population respectively, compared to 10 per 100,000 
population in Major cities). 
Hospitalisations rates for regular dialysis in Remote and very remote areas 
were higher than other areas 
In 2010–11, hospitalisation rates for regular dialysis for people in Remote and very remote areas 
were at least twice the rates in other areas. 
Aboriginal and Torres Strait Islander people are more likely than other 
Australians to be hospitalised with CKD 
In 2010–11, across all remoteness categories, the Indigenous age-standardised rate for regular 
dialysis hospitalisations was at least 7 times the rate for other Australians. This difference 
increased substantially in Outer regional and Remote and very remote areas. 
Incompleteness of Indigenous identification means that the number of hospitalisations, 
treated-ESKD cases, and deaths recorded are likely to underestimate the true level of 
morbidity and mortality in Aboriginal and Torres Strait Islander people.
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Introduction 
The prevalence of certain diseases, including chronic kidney disease (CKD), can be 
correlated with where people live. It is known that those living in rural and remote areas 
have a higher incidence of hospitalisation for CKD and CKD-related deaths (AIHW 2009).  
This report uses the Australian Bureau of Statistics (ABS) Australian Standard Geographical 
Classification (ASGC) system to group Australia into areas such as Major cities, Remote and 
Very remote (see Appendix B for more detail). 
The prevalence and incidence of end-stage kidney disease (ESKD) varies with location (Cass 
et al. 2001). ESKD occurs when kidney function has deteriorated to such an extent that 
kidney replacement therapy (KRT), in the form of dialysis or kidney transplantation, is 
required for patient survival.  
Box 1.1: Terminology 
Chronic kidney disease  
All kidney conditions where a person has evidence of kidney damage and/or reduced 
kidney function, lasting at least 3 months, regardless of the specific diagnosis of disease or 
condition causing the disease. 
End-stage kidney disease 
The most severe form of chronic kidney disease, also known as Stage 5 chronic kidney 
disease or kidney failure. 
Incidence 
The number of new cases (of an illness, disease or event) occurring during a given period. 
Prevalence 
The number or proportion (of cases, instances) present in a population at a given time. 
In Australia, ESKD rates are higher for those living in remote areas than for urban dwellers 
(Cass et al. 2001). This finding is strongly linked to the high proportion of Aboriginal and 
Torres Strait Islander people in these areas, for whom the incidence rate of treated-ESKD is 
around 20 times as high as for non-Indigenous people in the same areas. In Major cities, the 
Indigenous rate of treated-ESKD, although still unacceptably high, falls to 4 times the  
non-Indigenous rate (AIHW 2011b). 
There are a number of different CKD and ESKD data sources that include information on 
Indigenous status. However, the accuracy of identification may vary by data collection and 
region, and data collection methods may also vary. Incompleteness of Indigenous 
identification means that the number of hospitalisations and deaths recorded are an 
underestimate of the true level of morbidity and mortality of Aboriginal and Torres Strait 
Islander people.  
Socioeconomic factors can also influence disease rates and treatment status, and location can 
be a proxy measure of socioeconomic position. While more people living in 
socioeconomically disadvantaged areas are from major urban centres, they tend to be  
over-represented in smaller towns and in geographically isolated communities (ABS 2000). 
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Treatment can also vary by location due to a combination of service availability and patient 
factors. For example, it is known that patients living in Remote and Very remote areas are less 
likely to receive a kidney transplant (ANZDATA 2012). This may be due to the combination 
of a higher proportion of Aboriginal and Torres Strait Islander people (who have lower 
transplant rates) in these areas (AIHW 2012a) and greater distance from major hospitals.  
Box 1.2: Aboriginal and Torres Strait Islander people 
Aboriginal and Torres Strait Islander people have higher rates of chronic kidney disease 
and other chronic conditions compared to other Australians. 
Population distribution 
Aboriginal and Torres Strait Islander people make up 2.5% of the total Australian 
population and are more likely to live in Remote and Very remote areas compared to  
non-Indigenous Australians (see Chapter 5). 
To further complicate analyses, it is likely that some patients move to receive treatment, and it 
is not always possible to account for this in the analysis of available data. In addition, 
treatment practices in Australia vary by state and territory, due to a combination of 
remoteness, socioeconomic factors, physician preferences and availability of local training 
(George 2009).  
Across all remoteness categories, most KRT-treated-ESKD patients are treated with dialysis 
rather than a kidney transplant (AIHW 2012a). Dialysis treatment is usually performed ‘in-
centre’, rather than in the home, and one of the main issues these patients face is the burden 
of travel. Apart from those who have dialysis delivered in their homes, most dialysis patients 
must travel to a hospital or specialist centre several times a week.  
For many people, particularly those from rural and remote areas, a diagnosis of ESKD means 
relocating to live within a reasonable travel time of where their dialysis will be provided. A 
large international study has shown that longer travel time is significantly associated with 
greater mortality risk and decreased health-related quality of life (Moist et al. 2008). While 
the full significance of travel burden is yet to be measured in the Australian context, it is 
recognised as one of the main reasons why some patients choose not to receive KRT  
(Morton et al. 2012). 
Purpose of the report 
The purpose of this report is to provide a detailed picture of the geographic distribution of 
CKD across Australia and to investigate the burden that travel and relocation places upon 
the ESKD patient population. Hospitalisation, deaths and treatment data are used to 
illustrate the distribution of the disease. Patient movement during the course of KRT 
treatment is also explored. Of particular interest is the disease burden on patients from rural 
and remote areas, particularly those areas with a higher proportion of Aboriginal and Torres 
Strait Islander people. 
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1 Chronic kidney disease 
Key points 
 People from Remote and very remote areas are more likely to be hospitalised for CKD than 
people from other areas. 
 The mortality rate for CKD-related deaths was higher in Remote and very remote areas 
than in other regions.  
 
While the prevalence of CKD in several countries has been reported at both national and 
state levels (McClellan et al. 2012), there is little information about its prevalence at sub-state 
levels. In contrast, ESKD has been reported at regional levels (see chapters 2–5).  
In the Australian context, the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study 
(AusDiab) provides national information on CKD prevalence. For more information on the 
AusDiab study, see Appendix B. This study included a biomedical component thereby 
allowing estimates of the prevalence of CKD to be made based on measured data. 
Biomedical data in the Australian Health Survey 2011–13 will enable future updates to this 
information. 
The AusDiab study collected information on people from urban and rural areas (Table 1.1), 
but due to the sampling methodology it under sampled from rural areas. Indigenous 
Australians were also under represented in the survey, making up only 0.8% of the AusDiab 
sample (Dunstan et al. 2002), compared to the national proportion of 2.5%. As a result of the 
sampling methodology, the AusDiab study may underestimate geographical differences in 
CKD prevalence. The survey found no difference across regions in the prevalence of earlier 
stages (1–2) of CKD, but the prevalence for stages 3–5 was 1.2 times as high in rural than in 
urban areas (see Box A1 in Appendix A for CKD staging).  
Table 1.1: Prevalence of chronic kidney disease in Australia by location, 1999–2000 
 Prevalence 
(b)
 (%) 
Stage of chronic kidney disease
(a)
 Urban Rural Total 
Stages 1–2 5.6 5.6 5.6 
Stages 3–5 7.1 8.6 7.8 
(a)  Stages of CKD were developed by the United States Kidney Disease Outcome Quality Initiative (K/DOQI) (National Kidney Foundation of 
America 2002). 
(b)  Prevalence estimates were determined by calculating estimated glomerular filtration rates based on blood creatinine levels. The Modification 
of Diet in Renal Disease ‘175’ formula was used as recommended by the Australasian Creatinine Consensus Working Group (Mathew et al. 
2007). 
Note: Evidence of kidney damage for stages 1 and 2 was determined by presence of albuminuria or proteinuria. 
Source: AIHW analysis of the 1999–2000 AusDiab study. 
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CKD hospitalisations 
Hospitalisation data is another source of regional information on CKD as it includes 
diagnosis information and the geographic location of the patient’s residence. It is important 
to note that people who are hospitalised with CKD will most likely have a more advanced 
form of the disease. While the hospitalisation data presented here do not capture all cases of 
CKD, they do provide an indication of the level of serious disease requiring hospitalisation. 
These data do not include non-admitted patient activity in hospitals. For information on the 
scope and coverage of hospitalisation data, see Appendix B. 
Data for each hospitalisation are based on information provided at the end of an episode of 
care, when the length of stay and procedures carried out are known and diagnostic 
information is more accurate.  
There are two distinct types of diagnoses recorded in the database—principal and additional. 
The principal diagnosis is the diagnosis established after study to be chiefly responsible for 
occasioning the patient’s episode of admitted patient care. An additional diagnosis is a 
condition or complaint that either coexists with the principal diagnosis or arises during the 
episode of care. Additional diagnoses are recorded if the conditions affect patient 
management (AIHW 2012b). For more information on hospitalisation data, see Appendix B. 
Regional variation 
In 2010–11, there were 33,882 hospitalisations for CKD as a principal diagnosis (excluding 
regular dialysis – refer to Appendix B for definition). Rates were similar for Major cities, Inner 
regional and Outer regional areas (close to 150 hospitalisations per 100,000 people) but higher 
in Remote and very remote areas; men in Remote and very remote areas were hospitalised at 1.5 
times the rate of those from Major cities (210 hospitalisations per 100,000 people compared to 
142) and women were hospitalised at 2.5 times the rate of those from Major cities (365 
hospitalisations per 100,000 people compared to 145) (Figure 1.1 and Table A1). The higher 
rates observed in Remote and very remote areas possibly reflects the higher proportion of 
Aboriginal and Torres Strait Islander people living in these areas.  
Compared to Indigenous males, Indigenous women have higher levels of albuminuria (the 
early marker of CKD) (Hoy et al. 2012) and also have higher rates of CKD and treated-ESKD 
(AIHW 2011b). The sex trend difference between Aboriginal and Torres Strait Islander 
women and men in non-urban areas is also reflected in other comparisons of CKD and ESKD 
rates presented in this report.  
The possible reasons for increased CKD rates in Aboriginal and Torres Strait Islander 
females compared to Aboriginal and Torres Strait Islander males from non-urban areas are 
complex and likely due to several factors. Lower numbers of nephrons (the functional units 
of the kidney) in females, combined with lower birth weight and excessive childhood 
infections are likely to play a role. These features are more common in female Aboriginal and 
Torres Strait Islanders from remote areas (Hoy et al. 2010; Hoy et al. 2012), as are higher rates 
of diabetes and obesity (both key CKD risk factors) (Hoy et al. 2012). 
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Note: Directly age-standardised to the Australian population as at 30 June 2001.     
Source: AIHW NHMD. 
Figure 1.1: Hospitalisations with a principal diagnosis of CKD (excluding regular dialysis), 2010–11 
In 2010–11, there were 140,136 hospitalisations where CKD was recorded as an additional 
diagnosis (excluding regular dialysis) and where a remoteness category could be allocated. 
As with hospitalisations where CKD was the principal diagnosis, rates were similar for Major 
cities, Inner regional and Outer regional areas at around 550 hospitalisations per 100,000 people 
but higher in Remote and very remote areas—almost twice the rate of Major cities (1,160 
hospitalisations per 100,000 people). Whereas men in non-remote areas were 1.4 to 1.6 times 
more likely to be hospitalised than women, in Remote and very remote areas women were 1.2 
times more likely to be hospitalised than men (1,285 hospitalisations per 100,000 people 
compared to 1,064) (Figure 1.2 and Table A2).  
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Note: Directly age-standardised to the Australian population as at 30 June 2001.    
Source: AIHW NHMD. 
Figure 1.2: Hospitalisations with an additional diagnosis of CKD (excluding regular dialysis),  
2010–11 
CKD deaths 
Data from the National Mortality Database (NMD) also provide information on 
geographical differences in CKD. The NMD maintains cause of death information for all 
deaths registered in Australia. CKD can be recorded as the underlying cause (the 
condition that initiated the train of morbid events leading directly to death), or an 
associated cause (causes, other than the underlying cause, that were instrumental in 
causing death). For more information on the NMD, see Appendix B. 
In 2010, CKD was recorded as an underlying or associated cause of death in 14,278 cases. 
CKD was recorded as the underlying cause of death in about one-fifth of these cases (1,331 
male and 1,652 female). There were 11,295 deaths where CKD was recorded as an 
associated cause of death—6,137 male deaths and 5,158 female deaths. 
Regional variation 
In 2010, there was clear regional variation in deaths where CKD was recorded as an 
underlying (Figure 1.3 and Table A3) or associated cause of death (Figure 1.4 and Table A4).  
The age-standardised mortality rate where CKD was the underlying cause was higher in 
Remote and very remote regions than in other regions. Differences between male and female 
rates varied across regions: 
• the rate was higher for males than females in Major cities and Inner regional areas, and 
approximately equal in Outer regional areas 
• the mortality rate was considerably higher for females (29 deaths per 100,000 population) 
than males (19 deaths per 100,000 population) in Remote and very remote areas. 
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Notes 
1. Directly age-standardised to the Australian population as at 30 June 2001. 
2. Deaths for 2010 are based on a preliminary version of cause of death data, and are subject to further revision.     
3. These data have not been adjusted for the additional deaths arising from outstanding registrations of deaths in Queensland in 2010. For 
more detail please refer to Technical note 3 in Causes of death, Australia, 2010 (ABS 2012b). 
Source: AIHW NMD. 
Figure 1.3: Deaths per 100,000 population where CKD was the underlying cause, 2010 
The mortality rate for CKD as an associated cause of death was higher for males than females 
across all regions. However, while the rate for males was roughly consistent across Major 
cities, Inner regional and Outer regional areas at just under 60 deaths per 100,000 population, it 
increased in Remote and very remote areas to almost 80 deaths per 100,000 population.  
The mortality rate for females increased gradually as remoteness increased from 32 deaths 
per 100,000 population in Major cities to 39 deaths per 100,000 population in Outer regional 
areas, but also spiked in Remote and very remote areas to 67 deaths per 100,000 population. 
Again, this possibly reflects the higher proportion of Aboriginal and Torres Strait Islander 
people (with correspondingly higher rates of CKD) living in Remote and very remote areas 
(Figure 1.4 and Table A4). 
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Notes 
1 Directly age-standardised to the Australian population as at 30 June 2001.  
2. Deaths for 2010 are based on a preliminary version of cause of death data, and are subject to further revision.  
3 These data have not been adjusted for the additional deaths arising from outstanding registrations of deaths in Queensland in 2010. For 
more detail please refer to Technical note 3 in Causes of death, Australia, 2010 (ABS 2012b).  
Source: AIHW NMD. 
Figure 1.4: Deaths per 100,000 population where CKD was an associated cause, 2010 
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2 Incidence of ESKD 
Key points  
During 2008–2010: 
 rates of new cases of treated-ESKD increased with increasing remoteness. 
During 2005–2007: 
 about two-thirds of all new cases of ESKD (both KRT-treated and non-KRT-treated) 
were in Major cities. 
 those living in Very remote areas had much higher overall incidence rates of ESKD. 
 people living in Remote and Very remote areas were more likely to receive KRT for their 
ESKD. 
 age-specific treatment rates did not differ systematically by remoteness. 
 
This next section gives an overview of geographical differences in the incidence of  
treated-ESKD and in the total incidence of ESKD. As with the CKD results in Chapter 1, each 
data source shows higher rates in Remote and Very remote areas. However, it is important to 
note that the majority of cases are actually in Major cities, due to the higher number of people 
living in these areas. 
New cases of treated-ESKD  
This section presents information on individuals commencing treatment with KRT. Due to 
the small number of cases in Remote and Very remote areas, 2008–2010 data have been 
combined in this section. 
In 2008–2010, more than half (65%) of the new cases of treated-ESKD were for people living 
in Major cities and only 6% of cases were from Remote and Very remote areas. After accounting 
for population size, and adjusting for differences in age-structures, the rate of new cases was 
highest in Remote and Very remote areas (19 and 44 per 100,000 population, respectively, 
compared to 10 per 100,000 population in Major cities) (Table 2.1 and Figure 2.1).  
Differences between male and female rates varied across regions: 
• In Major cities, male rates were almost 2 times as high as female rates (14 compared to 7 
per 100,000 population). 
• In Inner regional areas, male rates were around 1.8 times female rates (12 compared to 7 
per 100,000 population, respectively). 
• In Outer regional areas, male rates were around 1.5 times female rates (13 compared to 9 
per 100,000 population, respectively). 
• In Remote areas, rates for males and females were similar (around 19 per 100,000 
population). 
• In Very remote areas, female rates were around 1.7 times male rates (58 compared to 33 
per 100,000 population).  
 10 Chronic kidney disease: regional variation in Australia 
Table 2.1: New cases of treated-ESKD by geographical location of first treatment, 2008–2010  
  Major cities  Inner regional  Outer regional  Remote  Very remote 
 Number Rate
(a) 
 Number Rate
(a)
  Number Rate
(a)
  Number Rate
(a)
  Number Rate
(a)
 
 Male 2,902 13.5  874 12.3  442 13.1  101 19.6  92 33.4 
 Female 1,787 7.4  505 6.7  292 8.8  84 18.8  121 57.9 
 Persons 4,689 10.2   1,379 9.3   735 11.0   185 19.2   213 44.0 
(a) Treated-ESKD patients per 100,000 population, directly age-standardised to the 2001 Australian population. 
Source: AIHW analysis of ANZDATA Registry data.  
 
 
Note: Directly age-standardised to the 2001 Australian population. 
Source: AIHW analysis of ANZDATA Registry data. 
Figure 2.1: Rate of new cases of treated-ESKD by sex and geographical location of residence at first 
treatment, 2008–2010 
The rate of new cases of treated-ESKD increased with age in Major cities, Inner regional and 
Outer regional areas, peaking in the oldest age group (70 and over). In Remote and Very remote 
areas, the rate of new cases of treated-ESKD also increased with age, but peaked in the 60–64 
age group. The difference in age-related trends in Remote and Very remote areas compared to 
other areas, is likely due to the high proportion of Aboriginal and Torres Strait Islander 
people in these areas. Aboriginal and Torres Strait Islander people tend to start treatment for 
ESKD at an earlier age than non-Indigenous Australians (McDonald & Russ 2003).  
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Total incidence 
Traditionally, incidence data for ESKD in Australia have only been available for those 
treated with KRT, with virtually all of these cases recorded in the Australian and New 
Zealand Dialysis and Transplant (ANZDATA) Registry. As not all people will be suitable 
candidates for KRT, and some may choose not to take it up, this method of measuring 
incidence of ESKD underestimates the total incidence in the community. 
To estimate the total incidence of ESKD, the AIHW used data linkage to estimate the number 
of new cases of ESKD not treated with KRT (AIHW 2011a). The number of non-KRT-treated 
cases is estimated using a defined set of cause of death codes in the NMD, with the aim of 
counting people who died with ESKD in the study period but were not treated with KRT. 
This number is added to the number of dialysis and transplant cases recorded in the 
ANZDATA Registry. Data linkage is also used to ensure that people treated with dialysis or 
transplant who die during the study period are only counted once.  
There are various reasons why some patients do not receive KRT treatment for their ESKD, 
including medical reasons (such as suitability for KRT), accessibility of services, and personal 
choice. KRT is a complex treatment, and individual patients make choices based on their 
particular circumstances.  
For this analysis, patients are classified into areas of remoteness as specified in the ABS 
ASGC (see Appendix B for details). These areas are based on either a patient’s postcode at 
their first treatment (for patients who were KRT-treated and did not die during the  
2005–07 reference period) or their place of usual residence before their death (for non-KRT-
treated patients or KRT-treated cases that died during the reference period).  
In 2005–2007, when non-KRT-treated cases were added to treated cases from ANZDATA, the 
total number of new cases of ESKD increased by between 24.4% (in Very remote areas) and 
55.0% (in Inner regional areas) (Table 2.2). About two-thirds (8,825) of all new cases of ESKD 
were in Major cities (Table 2.2). 
Table 2.2: Total incidence of ESKD, by treatment status and geographical location, 2005–2007   
  Major cities Inner regional Outer regional Remote Very remote 
Number of cases 
KRT-treated 4,642  1,263  701  196  225  
Non-KRT-treated 4,184   1,543  748  94  73  
Total 8,825  2,806  1,449  290  299  
Age-standardised rate (per 100,000 population)
(a)
 
KRT-treated 10.9 9.2 11.3 21.5 52.0 
Non-KRT-treated 9.0 10.2 12.1 14.2 29.2 
Total 19.9 19.4 23.2 35.7 81.1 
(a) Directly age-standardised to the Australian population as at 30 June 2001. 
Note: Male and female counts may not add up to total numbers (persons) due to rounding associated with allocating cases to ASGC categories. 
Source: Linked ANZDATA Registry, AIHW National Mortality Database and National Death Index.   
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Those living in Remote and Very remote areas had much higher incidence rates of ESKD 
(Figure 2.2), particularly in younger age groups (AIHW 2011a). The higher overall rates seen 
in Very remote areas are likely to be driven by the relatively higher proportion of Aboriginal 
and Torres Strait Islander people in these areas—48% compared to 6% or less in Major cities 
and Regional areas (AIHW 2011b).  
Aboriginal and Torres Strait Islander females are more likely than Aboriginal and Torres 
Strait Islander males to develop ESKD in Remote and Very remote areas (AIHW 2011b). In 
contrast, non-Indigenous males are more likely to develop ESKD than non-Indigenous 
females. The higher proportion of Aboriginal and Torres Strait Islander people in Very remote 
areas (48% versus 2.5% of the total Australian population) likely contributes to the higher 
female rates seen in Very remote areas (Figure 2.2) (AIHW 2011a, 2011b). Conversely, in Major 
cities, Inner and Outer regional areas, males had higher rates of ESKD than females and similar 
rates to females in Remote areas (Figure 2.2 and Table A5). 
 
Note: Directly age-standardised to the Australian population as at 30 June 2001.     
Source: Combined data from the ANZDATA Registry, AIHW National Mortality Database and the National Death Index.     
Figure 2.2: Total incidence of ESKD by sex and geographical location, 2005–2007 
KRT treatment rates by geographical location 
In 2005–2007, the proportion of people with ESKD who were KRT-treated varied across 
geographic locations. People living in Remote and Very remote areas were more likely to be 
treated than those in Major cities, Inner and Outer regional areas (Table 2.2).  
In addition, it is also important to look at treatment rates by age, as younger patients are 
more likely to receive treatment (AIHW 2011a). This is reflected in the higher proportion of 
ESKD cases treated with KRT in Remote and Very remote areas where more than half (58%) of 
the new cases of ESKD are under the age of 60 compared to 19–27% of new cases in other 
areas. Consequently, when treatment rates are examined by age group, people from Remote 
and very remote areas do not have higher treatment rates (Figure 2.3). Comparisons are 
further complicated due to the small number of cases in Remote and very remote areas.  
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Source: Combined data from the ANZDATA Registry, AIHW National Mortality Database and the National Death Index.  
Figure 2.3: Proportion of new cases of ESKD treated with KRT, by geographical location and age 
group, 2005–2007 
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3 Prevalence and type of treatment for 
ESKD 
Key points 
At the end of 2010: 
 Remote and Very remote areas have higher prevalence rates of treated-ESKD than other 
areas. 
 The proportion of treated-ESKD patients treated with a functioning kidney transplant 
was lowest in Remote and Very remote areas. 
 Satellite haemodialysis was the most common form of dialysis treatment in all 
geographical locations. 
In 2010–11: 
 Hospitalisation rates for regular dialysis in Remote and very remote areas were at least 
twice as high as other areas. 
Treated-ESKD prevalence 
The ANZDATA Registry data records the postcode where KRT-treated-ESKD patients are 
currently living. This information has been used to assign a remoteness category based on 
the ASGC system (see Appendix B for details). 
At the end of December 2010, the rate of treated-ESKD was highest for people living in 
Remote and Very remote areas (142 and 175 per 100,000 population, respectively) (Table 3.1), 
after taking into account population size and adjusting for differences in age structure. 
Males had higher rates of treated-ESKD than females in Major cities, Inner regional and Outer 
regional areas. In contrast, the opposite trend occurred in Remote and Very remote areas. As 
with the incidence of treated-ESKD (Figure 2.1) and the total incidence of ESKD (Figure 2.2), 
higher rates of treated-ESKD for females in Remote and Very remote areas are likely due to the 
relatively high proportion of Aboriginal and Torres Strait Islander people making up the 
population in these areas.  
It is worth noting that a different pattern is seen for people starting treatment, as opposed to 
those currently receiving treatment. In 2008–10, the age-standardised rate for people starting 
KRT treatment in Very remote areas was 2.3 times the rate in Remote areas (see Chapter 2). The 
reason why the same level of difference was not seen for people currently receiving 
treatment for ESKD (Figure 3.1) may be due to patients from Very remote areas moving to 
access services or moving as their treatment becomes more complex (see Chapter 4 for more 
detail on patient movement).  
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Note: Directly age-standardised to the 2001 Australian population. 
Source: AIHW analysis of ANZDATA Registry data. 
Figure 3.1: Rates of treated-ESKD by sex and geographical location of residence, 31 December 2010 
Table 3.1: Treated-ESKD by geographical location of residence, 31 December 2010  
  Major cities  Inner regional  Outer regional  Remote  Very remote 
 Number Rate
(a) 
 Number Rate
(a)
  Number Rate
(a)
  Number Rate
(a)
  Number Rate
(a)
 
 Male 7,844 104.5   2,155 90.0   1,086 96.7   242 135.7   138 148.9 
 Female 5,054 62.5  1,339 54.2  739 67.1  236 151.3  148 213.2 
 Persons
(b)
 12,898 82.3   3,493 71.5   1,825 81.8   477 142.3   286 175.5 
(a) Treated-ESKD patients per 100,000 population, directly age-standardised to the 2001 Australian population. 
(b) Male and female numbers may not add up to total numbers (persons) due to rounding associated with allocating postcodes of residence to 
ASGC categories. 
Source: AIHW analysis of ANZDATA Registry data.  
Type of kidney replacement therapy by geographical location 
The proportion of treated-ESKD patients with a functioning transplant varied by 
geographical location of residence (Figure 3.2). At the end of 2010, around 44% of treated-
ESKD patients living in Major cities or Inner regional areas and 38% of ESKD patients living in 
Outer regional areas had a functioning kidney transplant. This compared to 9% in Remote 
areas and 26% in Very remote areas. 
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Source: AIHW analysis of ANZDATA Registry data. 
Figure 3.2: Proportion of ESKD patients receiving dialysis or with a functioning kidney transplant 
by geographical location of residence, 2010 
Dialysis treatment by geographical location of residence  
The treatment pattern for dialysis varied with geographical location (Figure 3.3). Satellite 
haemodialysis was the most common dialysis treatment in all geographical locations, but 
Remote areas had the highest proportion of patients receiving haemodialysis at satellite 
clinics (70%). The home haemodialysis rate was highest in Very remote areas (10%) but this 
was the least commonly used type of treatment in all areas. The peritoneal dialysis rate was 
also highest in Very remote areas (23%) and similar in all other areas (ranging from 16–20%). 
For more information on the modes of dialysis, see Box 1. 
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Box 1: Dialysis modalities 
Haemodialysis 
In haemodialysis, blood is diverted from the body to a dialysis machine, where it is filtered 
before being returned to the body. This type of dialysis can be done at home, in hospital, or 
in satellite clinics. The machine requires special plumbing and the patient must restrict their 
travel to places where dialysis facilities are available.  
In most cases, the patient requires assistance connecting to the machine, and a partner, 
relative or friend can train to do this for home dialysis patients. During haemodialysis, the 
patient is usually connected to the machine for about 4–5 hours 3 times per week, when all 
their blood passes through the machine about 6 times. 
If performed at home, patients may have the option of dialysing more frequently for a 
shorter period (5–7 times per week for about 2 hours) or nocturnally (6 nights per week for 
about 8 hours). During a haemodialysis session the patient is unable to move away from the 
machine, though they can sleep and perform activities such as reading, talking, or using a 
computer. 
Peritoneal dialysis 
In peritoneal dialysis, the abdomen is filled with sterile dialysis solution and the blood is 
filtered through the peritoneal membrane (which covers the abdominal cavity organs such 
as the stomach, liver and intestines). The dialysis solution contains a type of sugar (usually 
glucose or dextrose) which draws the waste products and extra fluid out of the blood, 
through the peritoneal membrane and into the solution. After a few hours, the used 
solution, now containing the wastes and extra fluid, is drained out of the body and replaced 
with fresh solution.  
This process is called an exchange and takes about 30–45 minutes. In between exchanges, 
the patient is free to continue their usual activities. The patient can either perform 
peritoneal dialysis during the day (continuous ambulatory peritoneal dialysis), usually 3 or 
4 times, or automatically at night using a machine for about 8–10 hours while the patient 
sleeps (automated peritoneal dialysis). As the necessary equipment is portable, peritoneal 
dialysis can be performed almost anywhere. The patient does not need to be in a hospital or 
clinic, and can usually manage the procedure without assistance. 
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Source: AIHW analysis of ANZDATA Registry data. 
Figure 3.3: Dialysis treatment type by geographical location of residence, 2010 
Irrespective of the mode of dialysis or where patients live, a very substantial time 
commitment is required for patients to receive adequate treatment. Satellite and hospital 
haemodialysis is usually carried out 3 times per week, each for 4–6 hours, whereas home 
haemodialysis can be carried out overnight (6–8 hours) on a more frequent basis. Continuous 
ambulatory peritoneal dialysis requires that the dialysis solution be exchanged every 4–6 
hours, taking around 45 minutes each time. With an automated peritoneal dialysis, these 
exchanges can occur automatically overnight but an exchange may still be required during 
the day.  
Patients living in isolated areas may be able to access in-home dialysis, or may need to travel 
long distances or relocate. There is some evidence that long travel times to dialysis treatment 
are associated with higher mortality rates (Moist et al. 2008).  
The combination of time demands and physical constraints that those on dialysis treatment 
experience can lead to major changes in established patterns of social and economic 
participation. Dialysis patients can also face significant financial hardship from loss of 
income and higher out-of-pocket health costs. They also experience relatively high rates of 
depression and other psychological or interpersonal difficulties (Chilcot et al. 2008; Lew & 
Piraino 2005). Home life may be significantly disrupted and family members may be 
required to act as carers, particularly if people opt for home dialysis services. 
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Hospitalisations for regular dialysis  
People with CKD, particularly those with ESKD, often require hospital services—in fact 
regular dialysis treatment is the most common reason for hospitalisation in Australia (AIHW 
2012b). 
A regular dialysis hospitalisation is defined in this publication as a hospitalisation with a 
principal diagnosis of ICD-10-AM code Z49.1 (haemodialysis) or Z49.2 (peritoneal dialysis).  
Hospitalisations for regular dialysis involve patients undergoing a formal hospital admission 
process, completing an episode of admitted patient care and being discharged from hospital. 
For a hospitalisation to record a principal diagnosis of ICD-10-AM codes Z49.1 or Z49.2, the 
intent for admission must be same day and the patient discharged on the same or next day of 
admission (NCCH (National Centre for Classification in Health) 2010), see Appendix B for 
more information. 
In 2010–11, the hospitalisation rate for regular dialysis (see Appendix B for definition) for 
people in Major cities was around 1.3 times as high as the rate in Inner regional areas (5,164 
compared with 3,937 per 100,000 population) and similar to the rate in Outer regional areas 
(4,823 per 100,000 population). Hospitalisation rates in Remote and very remote areas were at 
least twice the rates in other areas. Males were hospitalised at higher rates in Major cities, 
Inner regional and Outer regional areas, while females had higher hospitalisation rates in 
Remote and very remote areas (Figure 3.4 and Table A6).  
 Notes 
1. Directly age-standardised to the 2001 Australian population. 
2. Hospitalisations where the principal diagnosis was regular dialysis (ICD-10-AM codes Z49.1 or Z49.2 – see Appendix B).  
Source: AIHW NHMD. 
Figure 3.4: Hospitalisation rates for regular dialysis, by geographical location of residence, 2010–11 
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4 Movement for treatment 
Key point 
 ESKD patients from Remote and Very remote areas are more likely to change remoteness 
categories during the first year of their KRT treatment when compared to patients from 
other areas. 
 
When commencing or undergoing KRT, some people move their place of residence closer to 
where they receive treatment for their ESKD (Preston-Thomas et al. 2007). This relocation 
may be more common among Aboriginal and Torres Strait Islander patients than  
non-Indigenous patients. An Australia-wide study found that from 1999 to 2001, 50% of 
Aboriginal and Torres Strait Islander patients commencing dialysis had to relocate to access 
treatment. In remote regions, 78% of Aboriginal and Torres Strait Islander patients had to 
relocate from the community in which they lived prior to commencing treatment, compared 
with only 15% in urban areas (Preston-Thomas et al. 2007).  
High relocation rates place a heavy toll on both the individual and the community. 
Relocation affects patients’ quality of life, their willingness and capacity to maintain their 
treatment regimens and may result in financial hardship, and social and cultural isolation 
(Preston-Thomas et al. 2007). Conversely, others may be unable to move from major centres 
to rural/remote areas, or travel for work or pleasure, due to the need to stay near their place 
of treatment.  
For Aboriginal and Torres Strait Islander patients, the need to move away from kin and 
community to take up KRT often results in a loss of social and cultural connectedness, loss of 
autonomy and control, and loss of status and authority. Key family members and cultural 
leaders having to relocate can profoundly affect Aboriginal and Torres Strait Islander 
communities (George Institute 2011). It is important to note that not all people with ESKD 
who move after starting treatment are doing so to live closer to their treatment. 
The ANZDATA Registry collects information on postcode of residence at first treatment and 
at the end of the year. Although it is not possible from these data to assess if patients move 
before they start treatment, it is possible to assess if patients move to a different postcode 
after they commence treatment.  
Table 4.1 shows the proportion of patients that changed remoteness categories during their 
first year of treatment. Data were combined for 2005–10 due to small numbers in some 
regions (see Table A7). It can be seen that a large proportion (57%) of patients who lived in 
Very remote areas at the start of their first treatment changed to less remote areas during their 
first year of treatment. The percentage of people who changed remoteness categories 
decreased with decreasing remoteness. Only a small proportion of people moved in the other 
direction—to more remote locations. 
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Table 4.1: ANZDATA Registry incident cases: Remoteness category of residence at first treatment 
and at end of incident year (proportion): 2005–2010 
 Remoteness of residence at year end 
Remoteness of 
residence at first 
treatment 
 Major 
cities 
Inner 
regional 
Outer 
regional 
Remote Very 
remote 
Per cent 
moved 
Major cities 98.5 1.1 0.4 0.1 0.0 1.5 
Inner regional 3.6 95.1 1.1 0.2 0.0 4.9 
Outer regional 4.5 4.2 90.0 0.6 0.6 10.0 
Remote 8.3 3.0 8.3 78.1 2.3 21.9 
Very remote 6.0 1.1 22.0 28.3 42.7 57.3 
Notes  
1. Bolded proportions indicate no change in remoteness of residence. 
2. Postcodes were allocated to a remoteness category if more than 80% of that postcode fell in a region according to 2006 ASGC concordance. 1,118 
cases were excluded due to their postcode at entry or end survey not being allocated to a remoteness category. Time to movement could range from 1 
day to 364 days depending on when in the survey year a patient commenced treatment. 
Source: AIHW analysis of ANZDATA Registry data. 
 
Table 4.2 shows a comparison group from the Household, Income and Labour Dynamics in 
Australia (HILDA) Survey—a nationally representative panel survey, with coverage rules 
broadly in line with those that the ABS adopts in the monthly Labour Force Survey 
supplements (Summerfield et al. 2012) (see Appendix B).  
Data from this survey show the proportion of the Australian population who change 
remoteness categories over a year. Over the same period 2005–2010, movement between 
remoteness categories after 1 year was 1% for the population who commenced the year in 
Major cities, 4% for the population that commenced the year in Inner and Outer regional areas 
and 9% for people who commenced the year in Remote and very remote areas.  
When comparing ANZDATA Registry data to HILDA data, it is apparent that ANZDATA 
incident populations in Inner regional, Outer regional and particularly Remote and very remote 
areas move more than the general population in these areas— this is likely to be related to 
access to treatment. 
Table 4.2: HILDA Survey: Remoteness category of usual residence and remoteness category of 
usual residence 1 year ago (proportion), 2005–2010 (all age groups) 
  Place of usual residence at year 2 
Place of usual 
residence at 
year 1  
 Major cities Inner regional Outer regional Remote and 
very remote 
Per cent 
moved 
Major cities 98.6 1.1 0.2 0.1 1.4 
Inner regional 2.5 96.5 0.8 0.2 3.5 
Outer regional 1.9 1.9 95.8 0.4 4.2 
Remote and 
very remote 
2.7 2.2 4.3 90.8 9.2 
Notes  
1. Bolded proportions indicate no change in remoteness of residence. 
2. Postcodes were allocated to a remoteness category if more than 80% of that postcode fell in a region according to 2006 ASGC concordance.  
Source: AIHW analysis of the Household, Income and Labour Dynamics in Australia (HILDA) Survey (Waves 5–10).  
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5 Aboriginal and Torres Strait Islanders 
with CKD by remoteness 
Key points 
 Indigenous identification varies with remoteness in some of the data sources used to 
monitor CKD.  
 Consequently, the number of hospitalisations and deaths recorded are possibly an 
underestimate of the true level of morbidity and mortality of Aboriginal and Torres 
Strait Islander people. 
In 2010–11: 
 Aboriginal and Torres Strait Islander people were hospitalised with a principal 
diagnosis of CKD (excluding regular dialysis) at a higher rate than other Australians. In 
Remote and very remote locations, Aboriginal and Torres Strait Islander people were 
hospitalised at 8.1 times the rate of other Australians. 
 Aboriginal and Torres Strait Islander people were hospitalised with an additional 
diagnosis of CKD at a higher rate than other Australians. In Remote and very remote 
locations, Aboriginal and Torres Strait Islander people were hospitalised at 12.8 times 
the rate of other Australians. 
In 2008–10: 
 the rate of new cases of treated-ESKD increased with remoteness for Aboriginal and 
Torres Strait Islander people. The opposite was true for non-Indigenous Australians. 
 
Compared with other Australians, Aboriginal and Torres Strait Islander people tend to have 
excessive chronic disease morbidity and mortality—particularly those in remote 
communities—and CKD is no exception to this trend (AIHW 2011b).  
This chapter highlights differences in health status between the Aboriginal and Torres Strait 
Islander population and the non-Indigenous population. It also explores differences in CKD 
and ESKD rates using three data sources: the NHMD, the NMD and the ANZDATA 
Registry. The quality of Indigenous identification in these data sources is important to 
consider when interpreting these data, and this issue is discussed.  
Aboriginal and Torres Strait Islander population 
Knowing how many Aboriginal and Torres Strait Islander people there are and where they 
live is important information for ensuring the provision of culturally appropriate health 
services. 
The estimated number of people identified as being of Aboriginal and/or Torres Strait 
Islander descent at 30 June 2006 was around 517,000, representing 2.5% of the total 
Australian population. 
Almost one-third (32%) of the estimated resident Aboriginal and Torres Strait Islander 
population lived in Major cities; 21% lived in Inner regional areas; 22% in Outer regional areas; 
9% in Remote areas and 15% in Very remote areas (Table 5.1). In contrast, a much higher 
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proportion of the non-Indigenous population resided in Major cities (69%) and less than 2% 
in Remote and Very remote Australia (ABS 2009).  
Table 5.1: Indigenous and non-Indigenous populations by remoteness, 30 June 2006 
  Indigenous  Non-Indigenous 
Geographical 
location 
Number 
Proportion 
of total 
Indigenous 
population 
Proportion of 
regional 
population 
 
Number 
Proportion 
of total non-
Indigenous 
population 
Proportion of 
regional 
population 
Major cities  165,804   32.1  1.2   13,996,454   69.4  98.8 
Inner regional  110,643   21.4  2.7   3,974,764   19.7  97.3 
Outer regional  113,280   21.9  5.8   1,854,024   9.2  94.2 
Remote   47,852   9.3  15.2   267,199   1.3  84.8 
Very remote  79,464   15.4  48.0   86,017   0.4  52.0 
Total   517,043   100.0  2.5   20,178,458   100.0  97.5 
Source: ABS 2009. 
As a result of the difference in population distribution, the proportion of the population that 
is Aboriginal and Torres Strait Islander increased with geographic remoteness—from 1% of 
the total population living in Major cities to 48% of the population living in Very remote areas 
of Australia. 
In addition, proportionally the Aboriginal and Torres Strait Islander population is much 
younger than the non-Indigenous population (Figure 5.1) since:  
 children aged under 15 years comprised 38% of the total Aboriginal and Torres Strait 
Islander population (compared with 19% in the non-Indigenous population)  
 people aged 15–24 years comprised 19% of the Aboriginal and Torres Strait Islander 
population (compared with 14%)  
 only 3% of the Aboriginal and Torres Strait Islander population were aged 65 years 
and over (compared with 13%).  
These different age profiles reflect the higher rates of fertility among Aboriginal and Torres 
Strait Islander people, and because they typically die at younger ages than non-Indigenous 
Australians (ABS 2009). 
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Source: ABS 2010. 
Figure 5.1: Estimated resident population by age, sex and Indigenous status, Australia, 2006 
Reporting on CKD and ESKD by Indigenous status 
and remoteness 
There are a number of different data sources used to monitor CKD and ESKD that include 
information on Indigenous status. However, the accuracy of identification may vary by data 
collection and region, and the method of collecting these data may also vary. This report uses 
three main sources of data which include variables by Indigenous status and remoteness.  
National hospital data 
A recent study by the AIHW assessed the quality of Indigenous identification in national 
hospital data. An estimated 88% of Aboriginal and Torres Strait Islander patients were 
correctly identified in Australian public hospital admission records from April 2011 to June 
2012 (AIHW 2013). The study recommends reporting aggregate national hospital data by 
Indigenous status for all states and territories for 2010–11 onwards. This differs from earlier 
advice (AIHW 2010) which recommended only using aggregate national hospital data from 
New South Wales, Victoria, Queensland, Western Australia, South Australia, and only public 
hospitals in the Northern Territory.  
The same study (AIHW 2013) also showed that Indigenous identification improved with 
increasing remoteness, ranging from 77% in Major cities to 99% in Very remote areas. While 
this study is helpful for providing guidelines on what is acceptable when assessing hospital 
data nationally, there has been no specific audit of Indigenous identification by remoteness 
areas for people presenting at hospitals with CKD.  
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It is unknown whether Aboriginal and Torres Strait Islander clients presenting with CKD are 
more or less likely to have their Indigenous status correctly recorded than those presenting 
with other conditions (AIHW 2010). Hence the following data should be interpreted with 
caution. 
Comparisons are made throughout the hospitalisations section of this chapter with ‘other 
Australians’, which includes hospitalisations where Indigenous status was not stated or 
inadequately described as well as those identifying as non-Indigenous. 
In 2010–11, Aboriginal and Torres Strait Islander people were hospitalised with a principal 
diagnosis of CKD (excluding regular dialysis) at a higher rate than other Australians in all 
geographical locations (Table 5.2). The greatest difference in hospitalisation rates between 
Aboriginal and Torres Strait Islander people and other Australians was in Remote and very 
remote locations, where Aboriginal and Torres Strait Islander people were hospitalised at 8.1 
times the rate of other Australians. 
Table 5.2: Hospitalisations with a principal diagnosis of CKD (excluding regular dialysis) by 
Indigenous status, 2010–11 
Geographical location 
Indigenous  Other Australians 
Rate ratio
(c)
 
Number Rate
(a)
 Proportion
(b)
  Number Rate
(a)
 Proportion
(b)
 
Major cities 373 332.4 1.7  21,672 151.4 98.3 2.2 
Inner regional 422 701.9 5.8  6,850 156.0 94.2 4.5 
Outer regional 517 738.5 16.2  2,666 133.5 83.8 5.5 
Remote and very remote 920 1,062.2 66.6  462 131.8 33.4 8.1 
(a) Hospitalisations per 100,000 population directly age-standardised to the 2001 Australian population. 
(b) Proportion of hospitalisations for a principal diagnosis of CKD (excluding regular dialysis) in geographical location. 
(c) Indigenous: Other Australian rate ratio. 
Source: AIHW NHMD. 
During the same period, Aboriginal and Torres Strait Islander people were more likely to be 
hospitalised with an additional diagnosis of CKD (excluding regular dialysis) across all 
remoteness categories (Table 5.3). Again, the greatest difference in hospitalisation rates was 
in Remote and very remote areas where Aboriginal and Torres Strait Islander people were 
hospitalised at 12.8 times the rate of other Australians. 
Table 5.3: Hospitalisations with an additional diagnosis of CKD (excluding regular dialysis) by 
Indigenous status, 2010–11  
Geographical location 
Indigenous  Other Australians 
Rate ratio
(c)
 
Number Rate
(a)
 Proportion
(b)
  Number Rate
(a)
 Proportion
(b)
 
Major cities 1,416 1,873.3 1.5  93,633 651.5 98.5 2.9 
Inner regional 944 2,074.4 3.4  26,518 552.2 96.6 3.8 
Outer regional 1,982 3,365.5 16.2  10,278 487.0 83.8 6.9 
Remote and very remote 3,963 5,588.5 73.9  1,402 436.0 26.1 12.8 
(a) Hospitalisations per 100,000 population directly age-standardised to the 2001 Australian population. 
(b) Proportion of hospitalisations an additional diagnosis of CKD (excluding regular dialysis) in geographical location. 
(c) Indigenous: Other Australian rate ratio. 
Source: AIHW NHMD. 
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In 2010–11, Aboriginal and Torres Strait Islander people had higher rates of hospitalisations 
for dialysis treatment across all remoteness categories (Table 5.4), largely reflecting the 
higher prevalence of treated-ESKD among Aboriginal and Torres Strait Islander people 
(ANZDATA 2012).  
The highest rate of dialysis hospitalisations for Aboriginal and Torres Strait Islander people 
was in Outer regional areas (closely followed by Remote and very remote areas), while the 
highest rate for other Australians was in Major cities.  
Table 5.4: Hospitalisations for regular dialysis by Indigenous status, 2010–11 
Geographical location 
Indigenous  Other Australians 
Rate ratio
(c)
 
Number Rate
(a)
 Proportion
(b)
  Number Rate
(a)
 Proportion
(b)
 
Major cities 33,166 42,802.5 4.1  775,160 5,361.2 95.9 8.0 
Inner regional 15,724 28,253.3 7.7  187,339 3,942.3 92.3 7.2 
Outer regional 44,430 76,598.5 39.7  67,364 3,182.5 60.3 24.1 
Remote and very remote 50,389 75,313.9 91.7  4,555 1,281.5 8.3 58.8 
(a) Hospitalisations per 100,000 population directly age-standardised to the 2001 Australian population. 
(b) Proportion of hospitalisations for regular dialysis in geographical location. 
(c) Indigenous: Other Australian rate ratio. 
Source: AIHW NHMD. 
National mortality data 
It is known that there is under-identification of Aboriginal and Torres Strait Islander people 
in mortality data and that Indigenous identification varies with geographical location 
(ABS 2012a). 
An ABS study in 2006, which linked Indigenous death records to census data, found that 
coverage of Indigenous deaths in death registration data is about 85% nationally, ranging 
from 76% in New South Wales to 99% in the Northern Territory. However, the estimates in 
this study were subject to limitations, including that 26% of Indigenous deaths did not link to 
census data (ABS 2008a, 2008b). The study did not estimate coverage rates by remoteness. 
Recently, the AIHW undertook a linkage project of several national data sets (NHMD, aged 
care, perinatal, and mortality data) to assess identification (AIHW 2012c). An 
‘ever-Indigenous’ approach was used in determining Indigenous status from the various 
data sets. The approach classifies the individual as Indigenous if indicated by any of the data 
sets. The death registration data set (2001–2006) used for this project contained 10,547 deaths 
listed as Indigenous. The linkage of the additional data sets to the death registration data 
identified 1,081, or 10%, more deaths than the 10,547 originally recorded on the death 
registration data as ‘Indigenous’.  
Similarly, the AIHW has linked ANZDATA Registry incidence data to national mortality 
data and taken a similar approach for records linked between 2004 and 2007. These 
combined data are also used to estimate the total incidence of ESKD (see Chapter 2 Total 
incidence section). The analysis was limited to jurisdictions where Indigenous identification 
in mortality data is considered of sufficient quality for national reporting—New South Wales 
(NSW), Queensland (Qld), South Australia (SA), Western Australia (WA) and Northern 
Territory (NT) (ABS 2012b).  
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Between 2004 and 2007, 425 cases were recorded as Indigenous in both ANZDATA incidence 
data and mortality data. A further 5.7% Indigenous cases (26 cases) were identified in the 
ANZDATA Registry that were not identified as Indigenous in mortality data. A similar 
proportion of linked cases (6.2%, 28 cases) were identified as Indigenous in mortality data 
but not the ANZDATA Registry (Table 5.5). When this is assessed by remoteness based on 
geographic variables from the mortality data, both data sources potentially misclassify a 
substantial proportion of Indigenous cases from Major cities in particular.  
Table 5.5: Potential misclassification (%) of Indigenous status in ANZDATA incidence data and 
mortality data, 2004–2007  
Geographical location Potential misclassification mortality data (%)
(a)
 Potential misclassification in ANZDATA (%)
(b)
 
Major cities 9.5 26.8 
Inner regional 7.9 6.6 
Outer regional 8.0 4.6 
Remote  5.0 0.4 
Very remote 0.2 0.9 
Total 5.7 6.2 
(a) Potential misclassification in mortality data = number of linked cases recorded as Indigenous in ANZDATA incidence data only/ the number of 
linked cases recorded as Indigenous in both mortality data and ANZDATA incidence data and in mortality data only. 
 
(b) Potential misclassification in ANZDATA incidence data = number of linked cases recorded as Indigenous in mortality data only/ the number of 
linked cases recorded as Indigenous in both mortality data and ANZDATA incidence data and in ANZDATA only. 
Note: Analysis limited to NSW, QLD, WA, SA, and NT. 
Source: Combined data from the ANZDATA Registry, AIHW National Mortality Database and the National Death Index. 
ANZDATA Registry 
The annual ANZDATA report, peer-reviewed articles and past AIHW publications have 
reported ANZDATA Registry data by Indigenous status and remoteness. As Indigenous 
identification in the ANZDATA Registry is based on self-identification in hospital data, it is 
generally considered comparable to hospital data in the level of identification.  
It has also been argued that because patients registered in the ANZDATA Registry have 
regular contact with services until death, and a new form is filled out annually, identification 
in the registry may be better than general hospital records (Cass et al. 2001). However, as 
noted above, a greater level of under-identification in Major cities has been found compared 
to other regions in the subset of data presented in Table 5.5. The extent to which this applies 
to other cases on the ANZDATA Registry is unknown. 
In 2008–2010, the rate of new cases of treated-ESKD increased with remoteness for 
Aboriginal and Torres Strait Islander people while the opposite was true for non-Indigenous 
Australians (Table 5.6). This trend for non-Indigenous Australians is in line with results from 
other recent studies (Gray et al. 2011). Some of this difference may be due to the better 
identification of Aboriginal and Torres Strait Islander people in Remote and Very remote areas. 
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Table 5.6: New cases of treated-ESKD by geographical location of first treatment and Indigenous 
status, 2008–2010  
Geographical location 
Indigenous 
 
Non-Indigenous 
Number Rate
(a)
 Proportion
(b)  Number Rate
(a)
 Proportion
(b) 
Major cities 111 44.7 2.4  4,577 10.6 97.6 
Inner regional 56 31.5 4.1  1,323 9.4 95.9 
Outer regional 157 83.1 21.4  578 9.1 78.6 
Remote and very remote 320 139.5 80.2  79 7.5 19.8 
(a) Treated-ESKD patients per 100,000 population, directly age-standardised to the 2001 Australian population. 
(b) Proportion of new cases of treated-ESKD in geographical location. 
Note: Male and female counts may not add up to total numbers (persons) due to rounding associated with allocating postcodes of residence to 
ASGC categories.    
Source: AIHW analysis of ANZDATA Registry data.  
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Appendix A: Supplementary tables  
Box A1: Stages of chronic kidney disease 
Stage 1: Kidney damage with normal kidney function (eGFR ≥ 90 mL/min/1.73 m2) 
Usually no symptoms but high blood pressure is more frequent than for patients without 
CKD. 
Stage 2: Kidney damage with mild loss in kidney function (eGFR 60–89 mL/min/1.73 m2) 
Most patients have no symptoms but high blood pressure is frequent. 
Stage 3a and b: Mild–moderate loss of kidney function (eGFR 45–59 mL/min/1.73 m2) 
(3a), or moderate–severe loss of kidney function (eGFR 30–44 mL/min/1.73 m2) (3b) 
Possibly no symptoms, or may experience an increased need to urinate during the night 
(nocturia), a mild feeling of being ill and loss of appetite. Common complications include 
high blood pressure, mineral and bone disorders, anaemia, sleep apnoea, restless legs, 
cardiovascular disease, malnutrition and depression. 
Stage 4: Severe loss of kidney function (eGFR 15–29 mL/min/1.73 m2) 
Symptoms are as for Stage 3, plus nausea, itching skin, restless legs and shortness of breath. 
Common complications of this stage are also as for Stage 3, along with electrolyte 
disturbances such as raised blood levels of phosphate and potassium and increased acidity 
of the blood. 
Stage 5: End-stage kidney disease (eGFR <15 mL/min/1.73 m2 or on dialysis) 
Symptoms are as for Stage 4. Additional common complications include inflammation of 
the tissue layers surrounding the heart, bleeding in the gastrointestinal tract, altered brain 
function and structure, and disturbances or structural or functional changes in the 
peripheral nervous system. 
Source: Adapted from Kidney Health Australia (2007, 2012). 
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Table A1: Hospitalisations with a principal diagnosis of CKD (excluding regular dialysis), 2010–11 
  Male  Female  Persons 
Geographical location Number Rate
(a) 
 Number Rate
(a)
  Number Rate
(a)
 
Major cities 10,534 142  11,511 145  22,045 142 
Inner regional 3,505 145  3,767 157  7,272 149 
Outer regional 1,487 133  1,696 158  3,183 144 
Remote and very remote 550 210  832 365  1,382 606 
(a) Hospitalisations per 100,000 population directly age-standardised to the 2001 Australian population. 
Note: Numbers exclude hospitalisations where geographic location of residence could not be assigned due to missing data, non-Australian 
residency etc. 
 
Source: AIHW NHMD. 
Table A2: Hospitalisations with an additional diagnosis of CKD (excluding regular dialysis),  
2010–11 
  Male  Female  Persons 
Geographical location Number Rate
(a) 
 Number Rate
(a)
  Number Rate
(a)
 
Major cities 53,655 752  41,394 458  95,049 585 
Inner regional 15,695 631  11,767 413  27,462 512 
Outer regional 7,073 629  5,187 440  12,260 528 
Remote and very remote 2,572 1,064  2,793 1,285  5,365 1,160 
(a) Hospitalisations per 100,000 population directly age-standardised to the 2001 Australian population. 
Note: Numbers exclude hospitalisations where geographic location of residence could not be assigned due to missing data, non-Australian 
residency etc. 
 
Source: AIHW NHMD. 
 Table A3: Deaths per 100,000 population where CKD was the underlying cause, 2010 
  Male  Female  Persons 
Geographical location Number Rate
(a) 
 Number Rate
(a)
  Number Rate
(a)
 
Major cities 867 12.5  1,056 9.6  1,923 10.8 
Inner regional 299 12.6  373 10.7  672 11.6 
Outer regional 123 12.1  166 12.2  289 12.2 
Remote and very remote 42 19.0   57 29.0   99 23.9 
(a) Deaths per 100,000 population directly age-standardised to the 2001 Australian population. 
Notes 
1. Directly age-standardised to the Australian population as at 30 June 2001. 
2. Deaths for 2010 are based on a preliminary version of cause of death data, and are subject to further revision.     
3. These data have not been adjusted for the additional deaths arising from outstanding registrations of deaths in Queensland in 2010. For 
more detail please refer to Technical note 3 in Causes of death, Australia, 2010 (ABS 2012b). 
Source: AIHW NMD. 
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Table A4: Deaths per 100,000 population where CKD was an associated cause, 2010 
  Male  Female  Persons 
Geographical location Number Rate
(a) 
 Number Rate
(a)
  Number Rate
(a)
 
Major cities 4,026 58.0  3,366 31.5  7,392 42.3 
Inner regional 1,342 55.4  1,135 33.7  2,478 43.2 
Outer regional 613 58.2  525 39.1  1,138 47.7 
Remote and very remote 155 79.2   132 67.1   287 72.4 
(a) Deaths per 100,000 population directly age-standardised to the 2001 Australian population. 
Notes 
1. Directly age-standardised to the Australian population as at 30 June 2001. 
2. Deaths for 2010 are based on a preliminary version of cause of death data, and are subject to further revision.     
3. These data have not been adjusted for the additional deaths arising from outstanding registrations of deaths in Queensland in 2010. For 
more detail please refer to Technical note 3 in Causes of death, Australia, 2010 (ABS 2012b). 
4. Male and female counts may not add up to total numbers (persons) due to rounding associated with allocating deaths to ASGC categories.  
Source: AIHW NMD. 
Table A5: Total incidence of ESKD, by sex and geographical location, 2005–2007 
  Major cities Inner regional Outer regional Remote Very remote 
 
Number of cases 
Males 4,847  1,507  759  144  129  
Females 3,978  1,299  690  147  169  
Total  8,825  2,806  1,449  290  299  
 
Age-standardised rate (per 100,000 population)
(a)
 
Males 25.3  23.5  26.1  36.6  65.5  
Females 15.6  15.9  20.6  36.2  99.5  
Total 19.9  19.4  23.2  35.7  81.1  
(a) Directly age-standardised to the Australian population as at 30 June 2001. 
Note: Male and female counts may not add up to total numbers (persons) due to rounding associated with allocating cases to ASGC categories.  
Source: Linked ANZDATA Registry, AIHW National Mortality Database and National Death Index. 
Table A6: Hospitalisations for regular dialysis by geographical location of residence, 2010–11 
  Male  Female  Persons 
Geographical location Number Rate
(a) 
 Number Rate
(a)
  Number Rate
(a)
 
Major cities 495,244 6,821  313,082 3,790  808,326 5,164 
Inner regional 122,581 4,960  80,482 3,045  203,063 3,937 
Outer regional 61,676 5,304  50,118 4,384  111,794 4,823 
Remote and very remote 23,828 8,975  31,116 13,851  54,944 11,144 
(a) Hospitalisations per 100,000 population directly age-standardised to the 2001 Australian population. 
Note: Numbers exclude hospitalisations where geographic location of residence could not be assigned due to missing data, non-Australian 
residency etc. 
 
Source: AIHW NHMD. 
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Table A7: ANZDATA Registry incident cases: Remoteness category of residence at first treatment 
and at end of incident year (number), 2005–2010 
 Remoteness of residence at year end 
Remoteness of 
residence at first 
treatment  
 Major cities Inner 
regional 
Outer 
regional 
Remote Very remote 
Major cities 9,138 99 33 10 0 
Inner regional 88 2,326 26 5 0 
Outer regional 57 53 1,128 7 8 
Remote 25 9 25 236 7 
Very remote 22 4 81 104 157 
Notes 
1. Bolded numbers indicate no change in remoteness of residence. 
2. Postcodes were allocated to a remoteness category if more than 80% of that postcode fell in a region according to 2006 ASGC 
concordance. 1,118 cases were excluded due to their postcode at entry or end survey not being allocated to a remoteness category. Time to 
movement could range from 1 day to 364 days depending on when in the survey year a patient commenced treatment. 
Source: AIHW analysis of ANZDATA Registry data. 
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Appendix B: Methods  
Age-specific rates 
Age-specific rates are calculated by dividing the number of cases occurring in each specified 
age group by the corresponding population in the same age group, expressed as a rate (for 
example, number per 100,000 persons). Information on the populations used in this report is 
provided in the section on populations below. 
Age-standardised rates 
Age-standardisation is a technique used to eliminate the effect of differences in population 
age structures when comparing rates for different periods of time, geographical areas, 
and/or population groups. Definitions are included in the National health data dictionary 
(Health Data Standards AIHW: Health Data Standards Committee 2006). 
There are two methods of age-standardisation, direct and indirect. The method used in this 
report is direct age-standardisation.  
Direct age-standardisation 
Direct age-standardisation applies the age-specific rates to a standard population in order to 
determine the rate that would have occurred in the standard population. This allows direct 
comparison of different rates applied to the same standard population. When selecting the 
standard population to use in age-standardisation, it is necessary to consider the population 
at risk. For the vast majority of rates which are age-standardised, such as the hospitalisation 
rates presented in this report, the total population is at risk. For these types of rates, the 
Australian population as at 30 June 2001 has been used as the standard.  
The method used for the calculation of age-standardised rates consists of three steps: 
Step 1: Calculate the age-specific rate for each age group. 
Step 2: Calculate the expected number of cases in each age group by multiplying the  
age-specific rate by the corresponding standard population to get the expected 
number of cases. 
Step 3: Find the sum of the expected number of cases in each age group, divide by the total 
of the standard population and multiply by 100,000. This gives the age-standardised 
rate. 
In general, the age-standardised rates presented in this report have been calculated using  
5-year age groups to over 75. Rates calculated using small numbers (less than five events in 
the numerator) can be unstable, show considerable fluctuation from year to year, and exhibit 
wide confidence intervals. In some cases, it has been necessary to combine younger age 
groups (0–29) to prevent this from occurring. 
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Populations used in this report 
Population data are used throughout this report to calculate rates. The population data used 
are estimated resident populations (ERPs) derived from the ABS Census of Population and 
Housing. ERPs adjust census data to add people that the census missed and people overseas 
on census night, and to remove overseas visitors. In between census years, the ERPs are 
updated using indicators of population change such as deaths, births and net migration. The 
ERPs used in this report are based on the 2006 Census.  
Where a rate is calculated for a calendar year (for example, with the ANZDATA Registry 
incidence data), the population used is the ERP as reported at 30 June of that year. Where a 
rate is calculated for a financial year, as with hospitalisation data, the population used is as at 
31 December. For example, to calculate the hospitalisation rate of the 2008–09 financial year, 
the ERP at 31 December 2008 would be used.  
Throughout this report, rates are age-standardised. In these cases, the standard population 
used to calculate the age-standardised rate is the Australian ERP as at 30 June 2001.  
Geographical structures used in report 
The data were analysed in this report using the ASGC. The ASGC is a hierarchical 
classification system of geographical areas and consists of a number of interrelated 
structures. It provides a common framework of statistical geography and enables the 
production of statistics which are comparable. 
The main structure used to analyse data in this report are Statistical Local Areas (SLAs). The 
SLA is a general purpose spatial unit. In aggregate, SLAs cover Australia without gaps or 
overlaps. In non-census years, the SLA is the smallest unit defined in the ASGC. In census 
years, a SLA consists of one or more whole collection districts, which are made up of mesh 
blocks (the smallest level of geography in census years).  
Reporting data by remoteness 
Comparisons of region in this report use the six ASGC remoteness areas, based on their 
distance from major population centres and services. The six remoteness areas are: 
• Major cities 
• Inner regional 
• Outer regional 
• Remote  
• Very remote 
• Migratory. 
Data from Migratory areas are not analysed in this report. The boundaries of the different 
remoteness areas are re-drawn after each census to account for changes to available services 
and population change. The remoteness areas used in this report are based on the 2006 
Census. 
Allocating cases to ASGC categories 
For remoteness allocations, different geographic variables are used to allocate persons to 
remoteness categories. For those records sourced from the ANZDATA Registry data, 
postcode at entry (incidence) and current postcode (prevalence) are used as a proxy for 
  Chronic kidney disease: regional variation in Australia 35 
postal area to agree with 2006 SLAs and then to remoteness categories. For records based on 
NMD and NHMD data, SLA of usual residence is used to concord to 2006 SLAs (where 
necessary) and then to remoteness categories. Refer to the NMD and NHMD data quality 
statements for more information on geographical variables in these data sources (see links 
below). 
AIHW National Mortality Database 
The AIHW NMD contains cause of death information for all deaths that occurred in Australia 
and were registered in Australia from 1965 onwards. The data are provided by the Registries 
of Births, Deaths and Marriages and the National Coroners Information System and the ABS 
codes these data. The data are maintained at the AIHW in the NMD. 
In this report, deaths for 2010 are based on preliminary data and are subject to further 
revision. Data are assembled based on the year of registration of death. While for the most 
part, year of death and registration coincide, there is some lag in death registrations such that 
approximately 5% of deaths are not registered until the next or a later year than when the 
death occurred. 
Cause of death information in the NMD for the years included in this report is classified 
according to the International Statistical Classification of Diseases and Related Health 
Problems, Tenth Revision (ICD-10). ICD-10 codes used to identify deaths for CKD are 
summarised in Table A8. 
The data in this report were extracted from the AIHW NMD in July 2012 and small changes 
may have occurred since this time. 
The data quality statements underpinning the AIHW National Mortality Database can be 
found in the following ABS publications:  
ABS Quality declaration summary for Causes of death, Australia, 2010 (ABS 2012b, ABS cat. no. 
3303.0) 
<http://www.abs.gov.au/Ausstats/abs@.nsf/0/D4A300EE1E04AA43CA2576E800156A24? 
OpenDocument> and  
ABS Quality declaration summary for Deaths, Australia, 2011 (ABS 2012a, ABS cat. no. 3302.0) 
<http://www.abs.gov.au/Ausstats/abs@.nsf/0/9FD0E6AAA0BB3388CA25750B000E3CF5?
OpenDocument.>. 
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Table A8: ICD-10(a) codes used to define diagnosis groups for CKD 
Group of chronic kidney disease ICD-10 codes 
Regular dialysis  
 Haemodialysis Z49.1* 
 Peritoneal dialysis Z49.2* 
Other  
 Diabetic nephropathy E10.2, E11.2, E12.2, E13.2, E14.2 
 Hypertensive kidney disease I12, I13, I15.0, I15.1 
 Glomerular diseases N00–N07, N08* 
 Kidney tubulo-interstitial diseases N11, N12, N14, N15, N16* 
 Chronic kidney disease N18 
 Unspecified kidney failure N19 
 Other disorders of kidney and ureter N25–N28, N39, E85.1^, D59.3^, B52.0^ 
 Congenital malformations Q60–Q63 
 Complications related to dialysis and kidney 
 transplant  
T82.4, T86.1 
 Preparatory care for dialysis Z49.0* 
 Kidney transplant and dialysis status Z94.0*, Z99.2* 
(a) ICD-10 codes are used to code mortality data. ICD-10-AM codes are used to code hospital morbidity data. 
^ These codes were used for identification in mortality data only. 
* These codes were used for identification in hospital morbidity data only. 
AIHW National Hospital Morbidity Database 
The NHMD contains demographic, diagnostic, procedural and duration of stay information 
on episodes of care for patients admitted to hospital. The database records information on 
patients who undergo a formal hospital admission process, complete an episode of admitted 
patient care, and ‘separate’ (discharge) from the hospital (AIHW 2012b). A record is included 
for each separation (hospitalisation), not for each patient, so patients who were hospitalised 
more than once in a given year have more than one record in the NHMD.  
State and territory health authorities supply data for this annual collection which the AIHW 
compiles and maintains. The database is episode-based and it is not possible to count 
patients individually. 
Diagnoses and procedures in the NHMD for 2010–11 included in this report are classified 
according to the International Statistical Classification of Diseases and Related Health 
Problems, Tenth Revision, Australian Modification (ICD-10-AM), 7th edition.  
ICD-10-AM codes used to define diagnosis groups for CKD are summarised in Table A6.  
The data quality statement for the AIHW NHMD can be found at on the AIHW’s 
MetadataOnline Registry (METeOR)—National Hospital Morbidity Database Data Quality 
Statement: 2010–11 <http://meteor.aihw.gov.au/content/index.phtml/itemId/511338>. 
Hospitalisations for regular dialysis 
A regular dialysis hospitalisation is defined in this publication as a hospitalisation with a 
principal diagnosis of ICD-10-AM code Z49.1 (haemodialysis) or Z49.2 (peritoneal dialysis).  
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For a hospitalisation to record a principal diagnosis of ICD-10-AM codes Z49.1 or Z49.2, the 
intent for admission must be same day and the patient discharged on the same or next day of 
admission. In cases where the intent of a regular dialysis admission was same day, but it was 
extended due to some other condition or complication of treatment, the condition 
responsible for extending the patient’s length of stay is coded as the principal diagnosis, and 
regular dialysis (Z49.1 or Z49.2) is coded as an additional diagnosis. Where a kidney dialysis 
episode of care was multi-day and the intent for admission was not same day, the condition 
necessitating the admission was coded as the principal diagnosis. In these circumstances, 
kidney dialysis was indicated by the procedure code (NCCH 2010). 
Although 23,000 occasions of non-admitted patient occasions of dialysis service were 
provided in public acute hospitals during 2010–11, these are not recorded in the NHMD 
(AIHW 2012b).  
Indigenous identification in national hospital data 
In a recent study by the AIHW which assessed quality of Indigenous identification in 
national hospital data, an estimated 88% of Aboriginal and Torres Strait Islander patients 
were correctly identified in Australian public hospital admission records from April 2011 to 
June 2012 (AIHW 2013). The study recommends reporting aggregate national hospital data 
by Indigenous status for all States and Territories for 2010–11 onwards. This report follows 
that recommendation. 
The data in this report were extracted from the AIHW NHMD in July 2012 and small 
changes may have occurred since this time. 
Australia and New Zealand Dialysis and Transplant Registry 
In Australia and New Zealand, all people receiving KRT where the intention to treat is long 
term—that is, kidney function is not expected to recover—are registered with the 
ANZDATA Registry. The registry compiles data on incidence and prevalence of  
treated-ESKD, complications, comorbidities and patient deaths. All relevant hospitals and 
related dialysis units participate. While patients may opt out of having part or all of their 
data recorded, this rarely happens.  
The interpretation and reporting of ANZDATA Registry information in this report has been 
undertaken by the AIHW, and does not represent ANZDATA Registry policy or 
interpretation. 
Information about the data quality of ANZDATA can be found in the The 34th Annual 
ANZDATA Report 2011 (ANZDATA 2012) 
<http://www.anzdata.org.au/v1/report_2012.html>. 
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Australian Diabetes, Obesity and Lifestyle Study  
The AusDiab study, conducted by the International Diabetes Institute in 1999–2000, was 
designed to provide national estimates of the prevalence of diagnosed and undiagnosed 
diabetes.  
It also provided national measurements of eGFR, albuminuria, proteinuria, haematuria, 
blood pressure, blood lipids, blood glucose, body fat, height and weight, and waist and hip 
circumference, as well as self-reported information on cardiovascular disease,  
anti-hypertensive and lipid lowering medication use, diet, smoking, alcohol consumption, 
physical activity, and general health and wellbeing.  
The study collected information in urban and non-urban areas in all states and the Northern 
Territory from more than 11,000 people aged 25 years and over who underwent a physical 
examination. This represents a response rate of 37% (Dunstan et al. 2002). Through linkage to 
the National Death Index, associations between indicators of CKD and mortality were also 
obtained. 
The target population of non-institutionalised adults aged 25 years and over residing in 
private dwellings in each of the six states and the Northern Territory were included in the 
survey if they had resided at the address for a minimum of 6 months prior to the survey. 
Visitors to private dwellings were not included (Dunstan et al. 2002). 
A stratified cluster sampling method was used, involving seven strata (six states and the 
Northern Territory) and clusters based on census Collector Districts (CDs—the smallest 
geographic unit defined by the Australian Bureau of Statistics at each census, with an 
average of 225 dwellings each). Within each state, six CDs were randomly selected with a 
selection probability proportional to the population size (population aged over 25 years). 
Due to the logistic and economic constraints of the survey, and to avoid the bias of including 
an unrepresentative number of high prevalence groups, the following exclusion criteria were 
adopted: 
 CDs containing fewer than 100 persons aged 25 years and over 
 CDs that formed part of a SLA that was classified as 100% rural according to 1996 
Census data 
 CDs that contained more than 10% Indigenous population (Dunstan et al. 2002). 
Information about the data quality of the AusDiab study can be found in The Australian 
Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates (Dunstan et al. 
2002). 
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The Household, Income and Labour Dynamics in Australia Survey 
This paper uses unit record data from the HILDA Survey. The HILDA project was initiated 
and funded by the Australian Government Department of Families, Housing, Community 
Services and Indigenous Affairs (FaHCSIA) and is managed by the Melbourne Institute of 
Applied Economic and Social Research (Melbourne Institute). The findings and views 
reported in this paper, however, are those of the author and should not be attributed to 
either FaHCSIA or the Melbourne Institute. 
The HILDA Survey is a household-based panel study which began in 2001 and has the 
following key features: 
 It collects information about economic and subjective wellbeing, labour market 
dynamics and family dynamics.  
 Special questionnaire modules are included each wave.  
 The Wave 1 panel consisted of 7,682 households and 19,914 individuals. In Wave 11, this 
was topped up with an additional 2,153 households and 5,477 individuals. 
 Interviews are conducted annually with all adult members of each household.  
 The panel members are followed over time. 
Information about the data quality of HILDA Survey data can be found in HILDA User 
Manual – Release 11 (Summerfield et al. 2012) 
<http://www.melbourneinstitute.com/downloads/hilda/User%20Manual/HILDA%20Use
r%20Manual%20Release_11.0.pdf>. 
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Glossary 
Albuminuria The presence of albumin (a type of protein) 
in the urine. Two positive tests for albumin 
in the urine over several weeks indicate 
persistent albuminuria, a first sign of diabetic 
kidney disease. 
Associated cause of death Causes, other than the underlying cause, that 
were instrumental in causing death. They 
encompass conditions that intervened or 
significantly contributed to death. 
Chronic kidney disease (CKD) Refers to all kidney conditions where a 
person has evidence of kidney damage 
and/or reduced kidney function, lasting at 
least 3 months, regardless of the specific 
diagnosis of disease or condition causing the 
disease. 
Dialysis An artificial method of removing waste 
substances from the blood and regulating 
levels of circulating chemicals—functions 
usually performed by the kidneys. 
End-stage kidney disease (ESKD) The most severe form of chronic kidney 
disease, also known as Stage 5 chronic 
kidney disease (CKD) or kidney failure. 
Estimated glomerular filtration rate (eGFR) A measure of kidney function which shows 
how well the kidneys are cleaning the blood. 
GFR is usually estimated (eGFR) from the 
results of the creatinine blood test. 
Haemodialysis A form of dialysis where a machine is 
connected to a person’s bloodstream to filter 
the blood externally. 
Incidence The number of new cases (of an illness, 
disease or event) occurring during a given 
period. 
Kidney replacement therapy (KRT)  Includes having a functional kidney 
transplant or receiving regular dialysis. 
Nephron The functional and structural units of the 
kidney responsible for the purification and 
filtration of the blood. 
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Peritoneal dialysis A form of dialysis where a solution is 
pumped into the abdominal cavity where the 
body’s own peritoneum membrane acts as a 
dialysis filter to remove waste products and 
water. 
Prevalence The number or proportion (of cases, 
instances) present in a population at a given 
time. 
Proteinuria  The presence of excess proteins (commonly 
albumin) in the urine likely to reflect a 
decline in kidney function. 
Satellite dialysis Dialysis performed in centres that are 
usually located away from their parent 
hospital so as to decrease the travel burden 
sometimes associated with accessing certain 
dialysis services. 
Underlying cause of death The disease or injury that initiated the train 
of events leading directly to death, or the 
circumstances of accident or violence that 
produced the fatal injury. 
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Chronic kidney disease
Regional variation in Australia
Chronic kidney disease is a common and serious 
problem in Australia and its management can be 
resource intensive, particularly for the most severe form 
of the disease: end-stage kidney disease. 
Rates of chronic kidney disease vary by geographic 
location. This report shows:
- people from Remote and very remote areas were 2.2 
times more likely to die from chronic kidney disease than 
people from Major cities.
- people from Very remote areas were at least 4 times 
more likely to start kidney replacement therapy (dialysis 
or kidney transplant) than people from non-remote 
areas.
